Drug intelligence / Profile preview

6G5j-IR800CW

Development stage
Unknown
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

6G5j-IR800CW is a **fluorescent imaging agent** consisting of the monoclonal antibody 6G5j conjugated to the near-infrared fluorescent dye IRDye800CW. The antibody component (6G5j) is a mouse IgG1 monoclonal antibody that binds to **carcinoembryonic antigen-related cell adhesion molecules (CEACAM)**, specifically CEACAM 1, 3, 5, 6, and 8. These molecules are highly expressed on colorectal cancer cells and other epithelial malignancies. The conjugate is developed primarily for **fluorescence-guided surgery** and **intraoperative imaging** of colorectal cancer, particularly **liver metastases**. The IRDye800CW component has an absorption maximum at 774 nm and emission maximum at 789 nm in PBS, enabling visualization in the near-infrared spectrum with minimal background interference. When administered intravenously, the conjugate specifically accumulates on CEACAM-positive tumors, allowing surgeons to visualize tumor margins and distinguish malignant tissue from normal tissue during surgical procedures. The imaging agent has been used in preclinical mouse models where it demonstrated effective tumor-to-liver ratios and enabled clear differentiation between tumor tissue and normal liver parenchyma when used in combination with ICG for dual-color imaging. The conjugate is prepared by coupling IRDye800CW-NHS ester to the 6G5j antibody through standard NHS ester chemistry, which forms amide bonds with lysine residues.

Other names
6G5j-IR800CWanti-CEACAM antibody-IRDye800CW
02

Targets

CEACAM1CEACAM3CEACAM5 (Carcinoembryonic antigen related cell adhesion molecule 5)CEACAM6CEACAM8 (Carcinoembryonic antigen-related cell adhesion molecule 8)

Beyond the preview

Go deeper on 6G5j-IR800CW.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6G5j-IR800CW.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call